- Home
- HUN vs LGND Comparison
HUN vs LGND Comparison
Compare HUN & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUN
- LGND
- Stock Information
- Founded
- HUN 1970
- LGND 1987
- Country
- HUN United States
- LGND United States
- Employees
- HUN N/A
- LGND N/A
- Industry
- HUN Major Chemicals
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- HUN Industrials
- LGND Health Care
- Exchange
- HUN Nasdaq
- LGND Nasdaq
- Market Cap
- HUN 2.4B
- LGND 2.1B
- IPO Year
- HUN 2005
- LGND 1992
- Fundamental
- Price
- HUN $12.05
- LGND $104.48
- Analyst Decision
- HUN Hold
- LGND Strong Buy
- Analyst Count
- HUN 9
- LGND 8
- Target Price
- HUN $15.00
- LGND $144.71
- AVG Volume (30 Days)
- HUN 4.2M
- LGND 102.0K
- Earning Date
- HUN 05-01-2025
- LGND 05-08-2025
- Dividend Yield
- HUN 8.29%
- LGND N/A
- EPS Growth
- HUN N/A
- LGND N/A
- EPS
- HUN N/A
- LGND N/A
- Revenue
- HUN $5,976,000,000.00
- LGND $181,488,000.00
- Revenue This Year
- HUN $4.09
- LGND $16.47
- Revenue Next Year
- HUN $4.65
- LGND $19.44
- P/E Ratio
- HUN N/A
- LGND N/A
- Revenue Growth
- HUN 0.02
- LGND 53.40
- 52 Week Low
- HUN $11.15
- LGND $72.61
- 52 Week High
- HUN $25.78
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- HUN 38.03
- LGND 46.11
- Support Level
- HUN $11.15
- LGND $99.24
- Resistance Level
- HUN $12.22
- LGND $107.37
- Average True Range (ATR)
- HUN 0.49
- LGND 4.05
- MACD
- HUN -0.02
- LGND -0.33
- Stochastic Oscillator
- HUN 32.19
- LGND 39.37
About HUN Huntsman Corporation
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.